scholarly journals Topical anti-inflammatory and anti-oxidative effects of porcine placenta extracts on 2,4-dinitrochlorobenzene-induced contact dermatitis

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Jae Hyeok Heo ◽  
Yoonki Heo ◽  
Hee Jung Lee ◽  
Minjee Kim ◽  
Ha Youn Shin
Author(s):  
Thea Magrone ◽  
Emilio Jirillo ◽  
Manrico Magrone ◽  
Matteo Antonio Russo ◽  
Paolo Romita ◽  
...  

Background: Our previous findings demonstrated that in vitro supplementation of polyphenols, extracted from seeds of red grape (Nero di Troia cultivar), to peripheral lymphomonocytes from patients affected by allergic contact dermatitis (ACD) to nickel (Ni) could reduce release of pro-inflammatory cytokines and nitric oxide (NO), while increasing levels of interleukin (IL)-10, an anti-inflammatory cytokine. Objective: To assess whether an intervention with oral administration of polyphenols leads to a reduction of peripheral biomarkers in ACD patients. Method: At T0, 25 patients affected by ACD to Ni were orally administered with 300 mg polyphenols prodie extracted from seeds of red grape (Nero di Troia cultivar) (NATUR-OX®) for 3 months (T1). Other 25 patients affected by ACD to Ni received placebo only for the same period of time. Serum biomarkers were analyzed at T0 and T1. In both groups seven drop outs were recorded. Result: At T1 in comparison to T0, in treated patients, values of IFN-γ, IL-4, IL-17, PTX3 and NO decreased, while IL-10 levels increased when compared with T0 values. Conversely, in placebo-treated patients no modifications of biomarkers were evaluated at T1. Conclusion: Present laboratory data rely on the anti-oxidant, anti-inflammatory and anti-allergic properties of polyphenols.


2018 ◽  
Vol 365 (3) ◽  
pp. 652-663 ◽  
Author(s):  
Stefania Petrosino ◽  
Roberta Verde ◽  
Massimo Vaia ◽  
Marco Allarà ◽  
Teresa Iuvone ◽  
...  

Author(s):  
Yu Pan ◽  
Zhao Liu ◽  
Yijie Wang ◽  
Linshen Zhang ◽  
Niying Chua ◽  
...  

Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation. Protease-digested lactoferrin fragments often exhibit improved therapeutic properties compared to full-length lactoferrin (flHLF). However, there are no studies on the use of protease-digested lactoferrin fragments to treat inflammation. Herein, we assess the anti-inflammatory properties of engineered recombinant lactoferrin fragments (rtHLF4, rteHLF1, and rpHLF2) on non-malignant colonic fibroblast cells and colorectal cancer cells. We found that rtHLF4 is 10 times more effective to prevent inflammation compared to flHLF. These results were investigated by looking into the reactive oxygen species (ROS) production, angiogenesis activity, and cellular proliferation of the treated cells. We have demonstrated in this study the anti-inflammatory properties of the flHLF and the various lactoferrin fragments. These results complement the anti-cancer properties of these proteins that were demonstrated in an earlier study.


2019 ◽  
Vol 137 ◽  
pp. 104969 ◽  
Author(s):  
Cristina Rigon ◽  
Marila Crivellaro Lay Marchiori ◽  
Fernanda da Silva Jardim ◽  
Natháli Schopf Pegoraro ◽  
Paula dos Santos Chaves ◽  
...  

2015 ◽  
Vol 26 (9) ◽  
pp. 688-693 ◽  
Author(s):  
Suzy Jo ◽  
Junghyun Ryu ◽  
Hanna Kim ◽  
Miyoung Kim ◽  
Mi Heon Ryu ◽  
...  

2004 ◽  
Vol 143 (5) ◽  
pp. 618-625 ◽  
Author(s):  
Eric Hyun ◽  
Manlio Bolla ◽  
Martin Steinhoff ◽  
John L Wallace ◽  
Piero Del Soldato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document